Business news from Ukraine

Work of 26 laboratories of Eskulab network is paralyzed due to unscrupulous actions of company’s co-owners

26 laboratories of the well-known medical chain Eskulab have suspended their work due to an internal conflict between the company’s co-owners. According to Serhiy Dyadyushko, one of the brand’s co-owners, his colleagues Denys Melnyk and Stanislav Luhovskyi, along with software administrator Igor Malinovsky, are committing illegal actions to gain full control over the company.

“Melnyk and Luhovskyi have repeatedly expressed their dissatisfaction with the official cash accounting. Their actions are aimed at gaining control over Eskulab in order to gain full access to its financial flows, to further direct them into their own hands, outside the official accounting and without paying taxes,” says Sergiy Dyadyushko.

He also claims that other co-owners offered to spend a significant portion of the cash outside the cash register and distribute it without paying taxes.

“They offered to spend the lion’s share of the funds received outside the cash accounting and distribute them without paying taxes among the company’s members. I categorically disagreed with such proposals and repeatedly informed them of my rejection of illegal actions. In this regard, Melnyk and Luhovskyi launched a raider attack to exclude me from the company’s shareholders by depriving me of my share,” said Diadiushko.

According to Dyadyushko, the raider attack included the systematic convening of general meetings of participants in violation of the established procedure, which led to the artificial creation of preconditions for his exclusion from the company. Melnyk and Luhovskyi also involved employees of the Lviv Directorate of Ukrposhta to ensure that he did not receive notices of the meeting.

“I have appealed to law enforcement agencies and am preparing documents to go to court. Despite constant psychological pressure and threats, I was forced to agree to resign as director and sign a new version of the charter to prevent my exclusion from the company,” he said.

This situation led to a temporary paralyzation of 26 laboratories of the Eskulab network in Kyiv, which negatively affected the provision of medical services to the population.

“As of today, having gained control over Eskulab, as a result of consistent raider actions, Melnyk and Luhovskyi, as well as Malinowski, who administers the software (computer program) of the company on the basis of which the latter conducts its business activities, have blocked me as a participant and medical director of Eskulab access to the said program and jointly withdraw cash from the company without paying taxes monthly in the amount of about UAH 20,000,000 Such actions of these persons lead to the actual non-receipt of biological products by the state budget. Because of this, 26 biomaterial collection points in Kyiv are actually unable to carry out their activities,” emphasizes the co-owner of the company.

Sergiy Dyadyushko considers these actions to be nothing more than a raider attack aimed at depriving him of his share in Eskulab.

“They demanded that I either resign as a director or they would exclude me from the company’s shareholders. The case has now been referred to law enforcement agencies. We are also preparing documents to go to court to restore my legal rights,” Dyadyushko said.

Established in 2009, Eskulab is a leading medical laboratory in western Ukraine that provides a wide range of laboratory services to the public with four laboratories and more than 150 biological sampling points.

In 2023, Eskulab paid UAH 33.8 million in taxes, including UAH 14.97 million in unified social tax, UAH 1.33 million in military duty, and UAH 14.034 million in personal income tax. It is one of the ten largest taxpayers in Lviv region.

The co-founders of PE “PSML ‘Eskulab’ are Dyadyushko, who owns 43% of the company, Luhovskyi (43%) and Melnyk (14%). The co-founders of Eskulab Center LLC are Dyadyushko, Luhovskyi and Melnyk, who each own 20% of the company, and Ruslana Soltani, who owns 40%.

, , , ,